In vitro concurrent paclitaxel and radiation of four vulvar squamous cell carcinoma cell lines

Cancer

Volumn 77, Issue 9, 1996, Pages 1940-1946

  Jaakkola, Misa ^a   Rantanen, Virpi ^a   Grénman, Seija ^a   Kulmala, Jarmo ^a   Grénman, Reidar ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

clonogenic assay; paclitaxel; radiosensitizer; squamous cell carcinoma; vulvar carcinoma

Indexed keywords

CISPLATIN; FLUOROURACIL; PACLITAXEL;

AREA UNDER THE CURVE; ARTICLE; CANCER RADIOTHERAPY; CLONOGENESIS; CONCENTRATION RESPONSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; RADIOSENSITIZATION; SQUAMOUS CELL CARCINOMA; VULVA CARCINOMA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, SQUAMOUS CELL; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LINEAR MODELS; PACLITAXEL; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; VULVAR NEOPLASMS;

EID: 0029915678     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960501)77:9<1940::AID-CNCR26>3.0.CO;2-Z     Document Type: Article

References (32)

1. Rowinsky EK, Cazenave LA, Donehower RC. Taxol: A Novel Investigational Antimicrotubule Agent. J Natl Cancer Inst 1990;82:1247-59.
2. Liebmann JE, Cook JA, Lipschultz C, Teague D, Fisher J, Mitchell JB. Cytotoxic studies of paclitaxel (Taxol®) in human tumour cell lines. Br J Cancer 1993;68:1104-9.
3. Holmes FA, Walters RS, Theriault RL, Forman AD, Newton LK, Raber MN, et al. Phase II trial of Taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 1991;83:1797-805.
4. McGuire WP. Taxol: A new drug with significant activity as a salvage therapy in advanced epithelial ovarian carcinoma. Gynecol Oncol 1993;51:78-85.
5. Murphy WK, Fossella FV, Winn RJ, Shin DM, Hynes HE, Cross HM, et al. Phase II study of Taxol in patients with untreated advanced non-small-cell lung cancer. J Natl Cancer Inst 1993;85:384-8.
6. Schiff PB, Horwitz SB. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 1980;77:1561-5.
7. Thomas G, Dembo AJ, DePetrillo J, Pringle J, Ackerman I, Bryson P, et al. Concurrent radiation and chemotherapy in vulvar carcinoma. Gynecol Oncol 1989;34:263-7.
8. Berek JS, Heaps JM, Fu YS, Juillard GJF, Hacker NF. Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva. Gynecol Oncol 1991;42:197-201.
9. Russell AH, Mesic JB, Scudder SA, Rosenberg PJ, Smith LH, Kinney WK, et al. Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva. Gynecol Oncol 1992;47:14-20.
10. Koh W-J, Wallace III HJ, Greer BE, Cain J, Stelzer KJ, Russell KJ, et al. Combined radiotherapy and chemotherapy in the management of local-regionally advanced vulvar cancer. Int J Radiat Oncol Biol Phys 1993;26:809-16.
11. Wahlen SA, Slater JD, Wagner RJ, Wang WA, Keeney ED, Hocko JM, et al. Concurrent radiation therapy and chemotherapy in the treatment of primary squamous cell carcinoma of the vulva. Cancer 1995;75:2289-94.
12. Grénman SE, Van Dyke DL, Worsham MJ, England B, McClatchey KD, Hopkins M, et al. Phenotypic characterization, karyotype analysis and in vitro tamoxifen sensitivity of new ER-negative vulvar carcinoma cell lines, UM-SCV-1A and UM-SCV-1B. Int J Cancer 1990;45:920-7.
13. Worsham MJ, Van Dyke DL, Grénman SE, Grénman R, Hopkins MP, Roberts JA, et al. Consistent chromosome abnormalities in squamous cell carcinoma of the vulva. Genes Chromosom Cancer 1991;3:420-32.
14. Grénman R, Burk D, Virolainen E, Buick RN, Church J, Schwartz DR, et al. Clonogenic cell assay for anchorage-dependent squamous carcinoma cell lines using limiting dilution. Int J Cancer 1989;44:131-6.
15. Rantanen V, Grénman S, Kulmala J, Grénman R. Simultaneous cisplatin and radiation in endometrial adenocarcinoma cell lines. Acta Oncol 1995;34:93-8.
16. Pekkola-Heino K, Kulmala J, Grénman S, Carey TE, Grénman R. Radiation response of vulvar squamous cell carcinoma (UM-SCV-1A, UM-SCV-1B, UM-SCV-2 and A-431) cells in vitro. Cancer Res 1989;49:4876-8.
17. Rantanen V, Grénman S, Kulmala J, Salmi T, Grénman R. Radiation sensitivity of endometrial carcinoma in vitro. Gynecol Oncol 1992;44:217-22.
18. Rantanen V, Grénman S, Kulmala J, Grénman R. The intrinsic radiosensitivity and sublethal damage repair capacity of five cervical carcinoma cell lines tested with the 96-well plate assay. J Cancer Res Clin Oncol 1995;121:230-4.
19. Grénman R, Burk D, Virolainen E, Wagner JG, Lichter AS, Carey TE. Radiosensitivity of head and neck cancer cells in vitro. A 96-well plate clonogenic cell assay for squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1988;114:427-31.
20. Kulmala J, Rantanen V, Pekkola-Heino K, Tuominen J, Grénman R. Dosimetry of irradiation models: the 96-well clonogenic assay for testing radiosensitivity of cell lines. Acta Oncol 1995;34:105-9.
21. Choo YC, Choy TK, Wong LC, Ma HK. Potentiation of radiotherapy by cis-dichlorodiammine platinum (II) in advanced cervical carcinoma. Gynecol Oncol 1986;23:94-100.
22. Souhami L, Seymour R, Roman TN, Stanimir GW, Trudeau M, Clark BG, et al. Weekly cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1993;27:871-8.
23. Geard CR, Jones JM, Schiff PB. Taxol and radiation. Monogr Natl Cancer Inst 1993;15:89-94.
24. Liebmann J, Cook JA, Fisher J, Teague D, Mitchell JB. In vitro studies of Taxol as a radiation sensitizer in human tumor cells. J Natl Cancer Inst 1994;86:441-6.
25. Steren A, Sevin B-U, Perres J, Angioli R, Nguyen H, Guerra L, et al. Taxol sensitizes human ovarian cancer cells to radiation. Gynecol Oncol 1993;48:252-8.
26. Choy H, Rodriguez FF, Koester S, Hilsenbeck S, Von Hoff DD. Investigation of Taxol as a potential radiation sensitizer. Cancer 1993;71:3774-8.
27. Lokeshwar BL, Ferrell SM, Block NL. Taxol enhances radiation-induced toxicity in prostatic tumor cells and delays tumor growth [abstract 2148]. Proc Am Assoc Cancer Res 1993;34:360.
28. Tishler RB, Geard CR, Hall EJ, Schiff PB. Taxol sensitizes human astrocytoma cells to radiation. Cancer Res 1992;52: 3495-7.
29. Liebmann J, Cook JA, Fisher J, Teague D, Mitchell JB. Changes in radiation survival curve parameters in human tumor and rodent cells exposed to paclitaxel (Taxol®). Int J Radiat Oncol Biol Phys 1994;29:559-64.
30. Geard CR, Jones JM. Radiation and Taxol effects on synchronized human cervical carcinoma cells. Int J Radiat Oncol Biol Phys 1994;29:565-9.
31. Hei TK, Piao CQ, Geard CR, Hall EJ. Taxol and ionizing radiation: Interaction and mechanisms. Int J Radiol Oncol Biol Phys 1994;29:267-71.
32. Milas L, Hunter NR, Mason KA, Kurdoglu B, Peters LJ. Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel. Cancer Res 1994;54:3506-10.